The results showed that the mRNA levels of BAD, CCND2 and PDGF-D were differentially expressed in prostate tumor tissues and normal prostate gland (Figs 3a–g and Supplementary Figs 2a–j, 3a–f and 4a–d). This evidence concerns the gene PDGFD and prostate neoplasm.